Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunity in hepatitis C virus infection

A M Prince1

  • 1Laboratory of Virology and Parasitology, Lindsley F. Kimball Research Institute of New York Blood Center, NY 10021.

Vox Sanguinis
|January 1, 1994
PubMed
Summary

Immunity following Hepatitis C virus (HCV) infection is weak, hindering vaccine development. HCV particles coated in lipoproteins prevent antibody binding, allowing reinfection even with the same viral strain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodology Used in DNA-Based Prophylactic and Therapeutic Immunization Against Hepatitis B Virus in Chimpanzees.

Methods in molecular medicine·2011
Same author

Development of the International Consortium for Blood Safety (ICBS) HCV panels.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2008
Same author

Schistosoma infection inhibits cellular immune responses to core HCV peptides.

Parasite immunology·2005
Same author

Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections.

Journal of viral hepatitis·2004
Same author

Perspectives on prophylactic and therapeutic immunization against hepatitis B and C viruses.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2002
Same author

Human milk contains detectable levels of immunoreactive leptin.

Advances in experimental medicine and biology·2002

Area of Science:

  • Virology
  • Immunology
  • Vaccine Development

Background:

  • Hepatitis C virus (HCV) infection typically results in weak and short-lived immunity.
  • Reinfection with the same HCV strain is possible, even in chronically infected individuals.
  • This immune evasion poses a significant hurdle for effective vaccine design.

Purpose of the Study:

  • To investigate the mechanisms behind weak immunity after HCV infection.
  • To understand why individuals can be reinfected with the same HCV strain.
  • To identify challenges in developing an HCV vaccine.

Main Methods:

  • Analysis of immune responses in HCV-infected individuals and chimpanzees.
  • Investigation of the physical characteristics of HCV virions.
  • Assessment of antibody binding to HCV particles.

Main Results:

  • HCV virions are coated with host-derived very-low-density lipoproteins (VLDL).
  • This lipoprotein coat masks viral epitopes, preventing effective antibody recognition and neutralization.
  • Immune responses are insufficient to clear the virus or prevent subsequent infections.

Conclusions:

  • The VLDL coating of HCV virions is a key mechanism for immune evasion.
  • This phenomenon explains the poor natural immunity and susceptibility to reinfection.
  • Overcoming this challenge is critical for the successful development of an HCV vaccine.

Related Experiment Videos